Director's Dealing • Feb 28, 2024
Director's Dealing
Open in ViewerOpens in native device viewer
28.2.2024 12:16:31 CET | Demant A/S | Other information disclosed according to the rules of the Exchange
Company announcement no 2024-05 28 February 2024
Notification on transactions pursuant to article 19 of the Market Abuse Regulation:
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|---|
| a) | Name | Niels Jacobsen |
| 2. | Reason for the notification | |
| a) | Position/status | Vice Chair of the Board of Directors |
| b) | Initial notification/amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
| a) | Name | Demant A/S |
| b) | LEI | 213800RM6L9LN78BVA56 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
| a) | Description of the financial instrument, type of instrument |
Shares |
| Identication code | DK0060738599 | |
| b) | Nature of the transaction | Sale |
| c) | Price(s) and volume(s) | Price Volume DKK 366.62 100,000 shares Minimum price DKK 364.55 Maximum price DKK 369.40 |
| d) | Aggregated information: - Aggregated volume - Price |
100,000 shares DKK 366.62 |
| e) | Date of the transaction | 27 February 2024 |
| f) | Place of the transaction | Nasdaq Copenhagen A/S |
| Further information: | |
|---|---|
| Mathias Holten Møller, Head of Investor Relations | |
| Peter Pudselykke, Investor Relations Officer Henrik Axel Lynge Buchter, Manager of External Communications |
|
| Phone +45 3917 7300 |
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, [email protected]
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and knowhow help improve people's health and hear-ing. We create life-changing differences through hearing health.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.